Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
Go back to Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026| (NASDAQ: IOVA) | Delayed: 8.70 -0.09 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.79 | 52 Week High | $ | |||
| Open | $8.69 | 52 Week Low | $ | |||
| Day High | $8.91 | P/E | N/A | |||
| Day Low | $8.48 | EPS | $ | |||
| Volume | 9,542,875 | |||||

